JOHNPHARMA
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
Bonus
Split
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Johnson Pharmacare do?
Johnson Pharmacare is in the business of wholesale and retail trade of all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods such as surgical instruments, contraceptives, photographic goods, oils, perfumes, cosmetics, patent medicines, soaps, artificial limbs, hospital requisites, proprietary medicines, veterinary medicines and tinctures extracts and to carry on the business of vialling, bottling, repacking, processing of tablets, capsules, syrups, injections, ointments, etc. and also to carry on the business of chemists, druggists, buyers, sellers, agents, distributors and stockiest of all kinds of pharmaceuticals and allied products.
Who are the competitors of Johnson Pharmacare?
Johnson Pharmacare major competitors are Mono Pharmacare, Cell Point (India), Shubhlaxmi Jewel Art, Ranjeet Mechatronics, AG Universal, IMEC Services, Sarthak Inds. Market Cap of Johnson Pharmacare is ₹33 Crs. While the median market cap of its peers are ₹33 Crs.
Is Johnson Pharmacare financially stable compared to its competitors?
Johnson Pharmacare seems to be less financially stable compared to its competitors. Altman Z score of Johnson Pharmacare is 0 and is ranked 8 out of its 8 competitors.
Does Johnson Pharmacare pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Johnson Pharmacare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Johnson Pharmacare allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances
How strong is Johnson Pharmacare balance sheet?
Johnson Pharmacare balance sheet is weak and might have solvency issues
Is the profitablity of Johnson Pharmacare improving?
The profit is oscillating. The profit of Johnson Pharmacare is -₹0.58 Crs for Mar 2025, -₹0.2 Crs for Mar 2024 and -₹1.29 Crs for Mar 2023
Is the debt of Johnson Pharmacare increasing or decreasing?
Yes, The net debt of Johnson Pharmacare is increasing. Latest net debt of Johnson Pharmacare is ₹1.08 Crs as of Sep-25. This is greater than Mar-25 when it was ₹0.58 Crs.
Is Johnson Pharmacare stock expensive?
Johnson Pharmacare is not expensive. Latest PE of Johnson Pharmacare is 0.0, while 3 year average PE is 54.92. Also latest EV/EBITDA of Johnson Pharmacare is 0.0 while 3yr average is 86.98.
Has the share price of Johnson Pharmacare grown faster than its competition?
Johnson Pharmacare has given better returns compared to its competitors. Johnson Pharmacare has grown at ~1.74% over the last 2yrs while peers have grown at a median rate of -20.63%
Is the promoter bullish about Johnson Pharmacare?
There is Insufficient data to gauge this.
Are mutual funds buying/selling Johnson Pharmacare?
There is Insufficient data to gauge this.
